Paper Details
- Home
- Paper Details
[Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
Author: FigullaH R, KreuzerH, LuigH, NieschlagF
Original Abstract of the Article :
Afterload reduction with angiotensin-converting enzyme inhibitors (ACE-inhibitors), such as captopril, is an established therapeutic measure in the adjunctive treatment of severe chronic heart failure. Unfortunately, several side effects and adverse reactions are related to this form of therapy. Cal...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/3109142
データ提供:米国国立医学図書館(NLM)
Nisoldipine and Captopril: A Tale of Two Heart Failure Treatments
Chronic heart failure is a complex condition, much like the ever-changing sands of the desert. It requires careful management and effective treatment strategies. This double-blind study explores the effects of two medications, nisoldipine (a calcium antagonist) and captopril (an ACE inhibitor), in the treatment of heart failure. The researchers compared the acute and chronic hemodynamic and clinical benefits of these two drugs in patients with severe heart failure.
Nisoldipine: A Short-Term Benefit in Heart Failure Management
The results showed that nisoldipine led to a significant increase in left ventricular ejection fraction (LVEF) within the first 3 days of treatment. However, this improvement disappeared after 3 months. While nisoldipine showed a short-term benefit, captopril demonstrated sustained improvement in hemodynamic parameters. This suggests that captopril may be a more effective long-term treatment for heart failure. However, the study's limited sample size warrants further research to confirm these observations.
Choosing the Right Path in Heart Failure Treatment
This study highlights the importance of considering the long-term effects of medications in managing chronic conditions like heart failure. While nisoldipine shows promise for short-term improvement, captopril appears to offer a more sustained benefit. The choice of treatment should be based on individual patient needs and medical history, carefully considering the potential benefits and risks of each medication. Consulting with a qualified healthcare professional is crucial for making informed decisions about heart failure treatment.
Dr.Camel's Conclusion
This study offers a valuable comparison of nisoldipine and captopril in heart failure treatment. While both medications offer benefits, captopril appears to provide more sustained improvement in hemodynamic parameters. The choice of medication should be personalized based on individual patient needs and medical history. This research provides a foundation for further investigation into the long-term effects of these medications in heart failure management.
Date :
- Date Completed 1987-06-29
- Date Revised 2013-11-21
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.